Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("LEVENSON, A. S")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 11 of 11

  • Page / 1
Export

Selection :

  • and

MCF-7 : The first hormone-responsive breast cancer cell lineLEVENSON, A. S; JORDAN, V. C.Cancer research (Baltimore). 1997, Vol 57, Num 15, pp 3071-3078, issn 0008-5472Article

Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotypeMAZAN-MAMCZARZ, K; HAGNER, P. R; CORL, S et al.Oncogene (Basingstoke). 2008, Vol 27, Num 47, pp 6151-6163, issn 0950-9232, 13 p.Article

Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptorLEVENSON, A. S; CATHERINO, W. H; JORDAN, V. C et al.Journal of steroid biochemistry and molecular biology. 1997, Vol 60, Num 5-6, pp 261-268, issn 0960-0760Article

Molecular classification of selective oestrogen receptor modulators on the basis of gene expression profiles of breast cancer cells expressing oestrogen receptor αLEVENSON, A. S; KLIAKHANDLER, I. L; SVOBODA, K. M et al.British journal of cancer. 2002, Vol 87, Num 4, pp 449-456, issn 0007-0920Article

Selective oestrogen receptor modulation : Molecular pharmacology for the millenniumLEVENSON, A. S; JORDAN, V. C.European journal of cancer (1990). 1999, Vol 35, Num 12, pp 1628-1639, issn 0959-8049Article

The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptorLEVENSON, A. S; TONENI, D. A; JORDAN, V. C et al.British journal of cancer. 1998, Vol 77, Num 11, pp 1812-1819, issn 0007-0920Article

Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell linesLEVENSON, A. S; JORDAN, V. C.Journal of steroid biochemistry and molecular biology. 1994, Vol 51, Num 5-6, pp 229-239, issn 0960-0760Article

Agonist activity of antiestrogen-receptor complexes to regulate urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) endogenous gene expression in breast cancer cellsLEVENSON, A. S; SVOBODA, K. M; KWAAN, H. C et al.Cancer letters. 1998, Vol 125, Num 1-2, pp 215-220, issn 0304-3835Article

Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptorLEVENSON, A. S; KWAAN, H. C; SVOBODA, K. M et al.British journal of cancer. 1998, Vol 78, Num 1, pp 88-95, issn 0007-0920Article

The key to the antiestrogenic mechanism of raloxifene is amino acid 351 (Aspartate) in the estrogen receptorLEVENSON, A. S; JORDAN, V. C.Cancer research (Baltimore). 1998, Vol 58, Num 9, pp 1872-1875, issn 0008-5472Article

Differential expression of gas and gadd genes at distinct growth arrest points during adipocyte developmentSHUGART, E. C; LEVENSON, A. S; CONSTANCE, C. M et al.Cell growth and differentiation. 1995, Vol 6, Num 12, pp 1541-1547, issn 1044-9523Article

  • Page / 1